Biology and genetics of atopic disease

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 796-803

  Casolaro, Vincenzo ^a   Georas, Steve N ^a   Song, Zhimin ^a   Ono, Santa Jeremy ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPY; FOOD ALLERGY; GENETIC PREDISPOSITION; INFLAMMATORY CELL; MEDIATOR RELEASE; SHORT SURVEY; URTICARIA;

EID: 0030448828     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80007-0     Document Type: Article

References (59)

1. Lichtenstein LM: Allergy and the immune system. Sci Am 1993, 269:117-154
2. Meyers DA, Bias WB, Marsh DQ: A genetic study of total IgE levels in the Amish. Hum Hered 1982, 32:15-23.
3. Ishizaka K: Mechanisms of reaginic hypersensitivity. Clin Allergy 1971, 1:9-24.
4. Austen KF: The Paul Kallas Memorial Lecture: from slowreacting substance of anaphalaxis to leukotriene C4 synthase. Int Arch Allergy Immunol 1995, 107:19-24.
5. Galli SJ, Gordon JR, Wershii BK: Cytokme production by mast cells and basophils. Curr Opin Immunol 1991, 3:865-873.
6. Ravetch JV, Kinet J: Fc receptors. Ann Rev Immunol 1993, 9:457-492.
7. Marsh DG, Norman PS: Antigens that cause atopic disease. In Immunological Diseases. Edited by Samter M, Talmage DW, Frank MM, Austen KF, Claman NH. Boston: Little, Brown and Company; 1988:982-1008.
8. Sutton BJ, Gould HJ; The human IgE network. Nature 1993, 366:421-428.
9. Ishizaka T, Mitsui H, Yanagida M, Miura T, Dvorak, A: Development of human mast cells from their progenitors. Curr Opin Immunol 1993, 5:937-943.
10. Zweiman B: The late phase reaction: role of IgE, its receptor and cytokines. Curr Opin Immunol 1993, 5:950-955.
11. Coombs RRA, Gell PGH: Classification of allergic reactions for clinical hypersensitivity and disease. In Clinical Aspects of Immunology. Edited by Gell PGH, Caombs RRA, Lachmann P. Oxford: Blackwell Scientific; 1975:761-781.
12. Burrows B, Martinez ED, Halonen M, Barbee RA, Cline MG: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1999, 320:271-277.
13. Norman PS: Modern concepts of immunotherapy. Curr Opin Immunol 1993, 5:968-973.
14. Verhoef A, Higgins JA, Thorpe CJ: Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp: identification of HLA-DR and -DO restricted T cell epitopes. Infect Immun 1993, 5:1589-1597.
15. Parronchi P, Macchia D, Biswas MP, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S: Allergen and bacterial-antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Nail Acad Sci USA 1991, 88:4538-4542.
16. + T cells. J Immunol 1992, 148:2291-2299.
17. Bradding P Feather IH, Howarth PH, Muller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH: Interleukin 4 is localized and released by human mast cells.. J Exp Med 1992, 176:1381-1386.
18. Brunner T, Heusser CH, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993, 177:605-611.
19. Pene J, Rousset F, Briers F, Chretien I, Bonneloy J-Y, Spits S, Yokcta T, Arai N, Arai K, Banchereau J et al.: IgE production by normal human B cells is induced by interleukin 4 and suppressed by interferon-γ and α and prostaglandin E2. Proc Nutl Acad Sci USA 1988, 85:6880-6884.
20. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993, 23:1445-1449.
21. Van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Weetland JKT, Mudde GC: Skin-derived aeroallergen-specific T-cell clones of Th2 phenolype in patients with atopic dermatitis. J Allergy Clin Immunol 1992, 90:184-192.
22. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C: Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992, 146:109-115.
23. Hemid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigar CJ, Bradley B, Durham SR, Collins JV, Jeffery PK: Expression of mRNA for interleukin-5 In mucosal bronchial biopsies from asthma. J Clin Invest 1991. 87:1541-1546.
24. Robinson DS, Hamid Q, Ying S, Tsicpoulos A, Barkans J, Bentley AM, Corrigan CJ, Durham SR, Kay AB: Predominant Th2-like bronchoalveloar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:295-304.
25. + T cells from allergic individuals. J Exp Med 1993, 178:2123-2130.
26. Varney VA, Hamid Q, Gaga M, Ying S, Jacobsen M, Frew AJ, Kay AB, Durham SR: Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993, 92:644-651.
27. Irving BA, Weiss A: The cytoplasmic domain of the T cell receptor chain is sufficient to couple to receptor-associated signal-transduction pathways. Cell 1991, 64:891-901.
28. + cells. Adv Immunol 1992, 53:1-29.
29. Zamel N, McClean PA, Sandell PR, Siminovitch KA, Slutsky AS; Asthma on Tristan da Cunha: looking for the genetic link. Am J Respir Crit Care Med 1996, 153:1902-1906.
30. Meyers DA, Postma DS, Panhuysen CIM, Xu J, Amelung PJ, Levitt RC, Bleecker ER: Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994, 23:464-470.
31. Chatham M, Bleecker ER, Smith PL. Rosenthal RR, Norman PS: A comparison of exercise, methacholine, and histamine hyperreactivity. J Allergy Clin Immunol 1981, 67:10-16.
32. Rosenwasser U: Genetics of asthma and atopy. Toxicol Lett 1996, 86:73-77.
33. Marsh DG, Hsu SH, Roebber M: HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from antigenic exposure. J Exp Med 1982, 155:1439-1451.
34. Marsh DG, Zwollo P. Huang SK, Ghosh B, Ansari AA: Molecular studies of human immune response to allergens. Cold Spring Harb Symp Guam Biol 1969, 54:459-470.
35. Marsh DG, Blumenthal MN, lahikawa T: HLA and specific immune responsiveness to allergens. In HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference, vol 1. Edited by Tsuji K, Aizawa M, Sasaiuki T. Oxford: Oxford University Press; 1992:765-771.
36. O'Hehir RE, Mach B, Berte C: Direct evidence for a functional role of HLA-DRB3 gene products in the recognition of Dermatophagoides spp by helper T cell clones. Int Immunol 1990, 2:885-692.
37. Young RP, Dekker JW, Wordsworth BP: HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994, 24:431-439.
38. Cookson WOCM, Sharp PA, Faux JA, Hopkin JM: Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989, 1:1292-1285.
39. Cookson WO: 11q and high-affinity IgE receptor in asthma and allergy. Clin Exp Allergy 1995, 25:71-73.
40. Cooksan WOCM, Young RP, Sandford AJ: Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1994, 543:1597-1600.
41. Sandford AJ, Shirakawa T, Moffat MF: Localization of atopy and β subunit of the high affinity IgE receptor (FeεRI) on chromosome 11 q. Lancet 1993, 341:332-324.
42. Shirakawa T, Li A, Dubowitz M: Variants of the β subunit of the high affinity immunoglobulin E receptor and atopy. Nat Genet 1994, 7:125-130.
43. Szepetowski P, Gaudray P: FCER1B, a candidate gene for atopy, is located in 11q13 between CD20 and TCN1. Genomes 1994, 19:399-400.
44. Metzger H: The high affinity receptor for IgE on mast cells. Clin Exp Allergy 1991, 21:269-279.
45. Jouvin MH, Numerof P, Kinet JP: Signal transduction through the conserved motifs of the high affinity IgE receptor Fc epsilon RI. Semin Immunol 1995, 7:29-35. The definitive review of signal transduction through the IgE receptor. Lucidly written and insightful analysis.
46. Weiss A: Signal transduction. Zapping tandem SH2 domains. Nature 1995, 376:17-18. A clear analysis of the role and special orientation of SH2 domains in lymphocyte receptor signaling.
47. Ravetch JV: Atopy and Fc receptors: mutation is the message? Nat Genet 1994, 7:117-118.
48. Marsh DG, Neely JD, Breaseale: Linkage analysis of IL4 and other chromosome 5q31. 1 markers and total serum immunoglobulin E concentrations. Science 1994, 264:1152-1526.
49. Song Z, Casolaro V, Monos D, Ono SJ: Identification of polymorphic nucleotides within the human interleukin-4 gene promoter which mediate overexpression of the gene. J Immunol 1996, 156:424-420. Demonstration that polymorphic nucleotides with the human IL-4 proximal promoter can affect promoter activity by altering the affinity of DMA-binding proteins for both positive regulatory element and negative regulatory element sequences. The electrophorectic mobility-shift assay alteration stabilizes AP-1 interaction near the P-sequence, an essential event in TCP-mediated activation of cytokine gene expression.
50. Ghan SC, Brown MA, Willcox TM, Li SH, Stevens SR, Tara D, Hanifin JM: Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory elements. J Invest Dermatol 1996, 106:1131-1136. Clear evidence from in situ hybridization analysis that atopic dermatitis patients have a higher frequency of IL-4-producing peripheral blood T cells when compared to normal subjects. By electrophorectic mobility-shift assay, the investigators show that nuclear extracts from twelve out of twelve patients with atopic dermatitis form an activation complex on the IL-4 promoter, compared to two out of twelve normal subjects. This seminal discovery suggests that the genes encoding IL-4 promoter binding proteins may themselves by atopy genes.
51. Kaplan MH, Schindler U, Smiley ST. Grusby MJ: State is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996, 4:313-319. One of a flurry of papers from Grusby's laboratory that have clearly demonstrated the role of STAT proteins in Th development. Once again, these are tempting targets for new drug design.
52. Ho IC, Hodge MR, Rooney JW, Glimcher LH: The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Ceff 1996, 85:973-983. A landmark publication in T cell development. Likely to have profound implications for several immunological diseases, and a good candidate for targeted immune modulation.
53. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T: Essential role of State in IL-4 signalling. Nature 1996, 380:627-330.
54. Mosmann TR: T lymphocyte subsets, cytokines, and effector functions. Ann NY Acad Sci 1992, 664:89-92.
55. Henkel G, Brown MA: PU1 and GATA: components of a mast cell-specific interleukin-4 Intronlc enhancer. Proc Natl Acad Sci USA 1994, 91:7737-7741.
56. Paraz VL, Lederer JA, Lichtman AH, Abbas AK: Stability of Th1 and Th2 populations. Int Immunol 1995, 7:869-875.
57. Lederer JA, Liou JS, Kim S, Rice N, Lichtman AH: Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells. J Immunol 1996, 156:56-63. An extremely important publication indicating that TCR stimulation fails to induce p65 (RelA) in Th2 cells. The paper also shows that Th1 and Th2 cells express different levels and/or different forms of IκBα, and that cytokines (but not TCR stimulation) modulate cytoplasmic IκB. The implications of the paper are that cytokines can modulate the Rel response to TCR stimulation suggesting that Rel proteins might contribute to Th differentiation. Indeed that Rel knockout mice do have abnormalities in Th development and cytokine production.
58. Casolaro V, Georas S, Song Z, Zubkoff ID, Abdulkadir SA, Thanos D, Ono SJ: Inhibition of NFATp-dependent transcription by NFκB: Implications for differential gene expression in T cell subsets. Proc Nat Acad Sci USA 1995, 92:11623-11627. A detailed molecular analysis of competition between NFAT and RelA proteins for the IL-4 P sequence, Identification of sequence divergence between the human and mouse P-sequences. A potential molecular basis for the findings of Lederer and Lichtman [57**].
59. Venkataraman L, Wang W, Sen R: Differential regulation of crel translocation in activated B and T cells. J Immunol 1996, 157:1149-1155. Clear biochemical evidence that various Rel family members are sequestered by distinct IκB polypeptides, providing a solution to distinct kinetics of Rel family nuclear translocation. Also a clear difference in PMA/ionophore response in B and T cells is shown.